Alopecia Areata: Pathogenesis, Diagnosis, And Therapies

Alopecia Areata (AA) is a chronic autoimmune disorder affecting about 2% of the global population, characterized by unpredictable hair loss due to immune attacks on hair follicles. The pathogenesis involves complex interactions between immune dysregulation, genetic predisposition, and environmental factors, with key immune players like CD8+NKG2D+ T cells and cytokines such as IFN-γ and IL-17A contributing to inflammation. Traditional treatments, including glucocorticosteroids and immunosuppressants, have limited efficacy, prompting interest in emerging therapies targeting pathways like JAK–STAT and PDE4. New treatments, including biologics, small-molecule drugs, and innovative techniques like microneedling and exosome therapy, show promise but require further research to confirm their effectiveness and safety. Understanding these mechanisms and developing targeted therapies are crucial for improving management and patient quality of life.